Etches RC. Patient-controlled analgesia. Surg Clin North Am 1999; 79:297–312.
43.
Austin KL, Stapleton JV, Mather LE. Multiple intramuscular injections: a major source of variability in analgesic response to meperidine. Pain 1980;8:47–62.
44.
Jain S, Datta S. Postoperative pain management. Chest Surg Clin North Am 1997;7:773–799.
45.
Egbert AM, Parks LH, Short LM, et al. Randomized trial of postoperative patient-controlled analgesia vs intramuscular narcotics in frail elderly men. Arch Intern Med 1990;150:1897–1903.
46.
Rawal N, Arn´er S, Gustafsson LL, et al. Present state of extradural and intrathecal opioid analgesia in Sweden. A nationwide follow-up survey. Br J Anaesth 1987;59:791–799.
47.
Rawal N. Epidural and spinal agents for postoperative analgesia. Surg Clin North Am 1999;79:313–344.
48.
Werawatganon T, Charuluxanun S. Patient controlled intravenous opioid analgesia versus continuous epidural analgesia for pain after intra-abdominal surgery. Cochrane Database Syst Rev 2005;1:CD004088.
49.
DeAndrade JR, Maslanka M, Maneatis T, et al. The use of ketorolac in the management of postoperative pain. Orthopedics 1994;17:157–166.
50.
Etches RC, Warriner CB, Badner N, et al. Continuous intravenous administration of ketorolac reduces pain and morphine consumption after total hip or knee arthroplasty. Anesth Analg 1995;81:1175– 1180.
51.
Macario A, Lipman AG. Ketorolac in the era of cyclo-oxygenase-2 selective nonsteroidal anti-inﬂammatory drugs: a systematic review of efficacy, side effects, and regulatory issues. Pain Med 2001;2:336– 351.
52.
Lowder JL, Shackelford DP, Holbert D, et al. A randomized, controlled trial to compare ketorolac tromethamine versus placebo after cesarean section to reduce pain and narcotic usage. Am J Obstet Gynecol 2003;189:1559–1562.
53.
Wischnik A, Manth SM, Lloyd J, et al. The excretion of ketorolac tromethamine into breast milk after multiple oral dosing. Eur J Clin Pharmacol 1989;36:521–524.
54.
Greer IA. Effects of ketorolac tromethamine on hemostasis. Pharmacotherapy 1990;10(Pt 2):71S–76S.
55.
Strom BL, Berlin JA, Kinman JL, et al. Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study. JAMA 1996;275:376–382.
56.
Feldman HI, Kinman JL, Berlin JA, et al. Parenteral ketorolac: the risk for acute renal failure. Ann Intern Med 1997;126:193–199.
57.